Researches

Retrospective analysis of 53 cases with borderline ovarian tumors

10.5350/BTDMJB201410106

  • Evrim Bostancı
  • Selçuk Ayas
  • Ayşen Boza
  • Ayşe Gürbüz
  • Ateş Karateke

Received Date: 25.09.2013 Accepted Date: 27.11.2013 Med J Bakirkoy 2014;10(1):27-32

Objective:

To determine of 53 cases with borderline ovarian tumors according to clinical features, treatment methods, recurrence and survival rates.

Material and Methods:

Fifty-three patients with borderline ovarian tumors operated in Zeynep Kamil Hospital between 2001-2011 are included. Demographic and clinical findings, surgical methods, wish for the preservation of fertility, recurrences and survivals were evaluated.

Results:

Average age of patients were 45.4±15.5. Time at diagnosis 56.6% of the patients were in postmenopausal, 43.4% of patients were in premenopausal period. %67.9 of the patients had serous, 26.4% of them had musinous histologic type and 5.7% of them had mixt type. Tumor markers were elevated (≥35IU/ml) in %62,3 of the patients before the surgery. One of the patients were treated with total abdominal hysterectomy (TAH) and bilateral salpingo-oophorectomy (BSO), 7 of the patients (13.2%) were treated with unilateral salpingoophorectomy (USO) and biopsy from other ovary, 14 of the patients (26.4%) were treated with USO+bilateral pelvic and paraaortic lymphadenectomy (BPPLND) and omentectomy, 31 of patients (58.5%) were treated with TAH+BSO+BPPLND+omentectomy. Forty-nine of the patients (92.45%) were stage I. 39.6% (n=21) of the patients were treated with fertility sparing surgery but five of them were reoperated in 1 year. Totally 30.2% (n=16) of the patients were treated with fertility sparing surgery. We have had 5 babies and 1 ectopic pregnancy after fertility sparing surgery. Furthermore we have not seen any recurrence during our follows-up.

Conclusion:

Borderline ovarian tumors have perfect prognosis. Conservative treatment of borderline ovarian tumors should be consider in patients with fertilty desire and at reproductive age but patients should be warned for recurrences rates. Our experiences are coherent with literature.

Keywords: Borderline ovarian tumor, fertility sparing surgery, survival